-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4-Amino-2-chloro-6,7-dimethoxyquinazoline, also known as "Clioquinol," is an antibiotic producer used to treat leishmaniasis and trypanosomiasis (Chagas disease).
The compound, which contains a quinoline structure, is manufactured through several steps in the chemical industry.
The following is a comprehensive overview of the process involved in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline.
Step 1: Synthesis of 2-Chloro-6,7-dimethoxyquinoline
The first step in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline involves the synthesis of 2-Chloro-6,7-dimethoxyquinoline.
The process typically involves the reaction of 2,6-dichloro-1,4-benzoquinone with sodium hydroxide, followed by treatment with sodium sulfate and sodium carbonate.
The product is then purified through recrystallization.
Step 2: Addition of Amine Group
The next step in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline involves the addition of an amine group to 2-Chloro-6,7-dimethoxyquinoline.
This process typically involves the reaction of the former compound with an amine such as ammonia or an aliphatic amine, in the presence of a suitable catalyst, such as hydrochloric acid or sulfuric acid.
The product is then purified through recrystallization.
Step 3: Addition of Methoxy Group
The final step in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline involves the addition of a methoxy group to the product obtained in the previous step.
This process typically involves the reaction of the product with methyl iodide in the presence of a suitable catalyst, such as sodium hydroxide or potassium hydroxide.
The product is then purified through recrystallization.
The above sequence of reactions provides a general outline of the process involved in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline.
However, the specific conditions used in each step may vary depending on the scale of production, the purity of the starting materials, and the desired product.
Additionally, the use of protecting groups and other synthetic techniques may be necessary to ensure the integrity of the product.
In conclusion, the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline is a multi-step process that involves several reactions and purification steps.
The compound is used as an antibiotic producer to treat leishmaniasis and trypanosomiasis, and its synthesis is critical for the production of these treatments.
The steps outlined above provide a general overview of the process involved in the instruction of 4-Amino-2-chloro-6,7-dimethoxyquinazoline, and further research is necessary to optimize the process for industrial scale production.